These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23353637)

  • 1. Optimization of the adult zebrafish ECG method for assessment of drug-induced QTc prolongation.
    Chaudhari GH; Chennubhotla KS; Chatti K; Kulkarni P
    J Pharmacol Toxicol Methods; 2013; 67(2):115-20. PubMed ID: 23353637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation.
    Milan DJ; Jones IL; Ellinor PT; MacRae CA
    Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H269-73. PubMed ID: 16489111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine.
    Hondeghem LM; Dujardin K; Hoffmann P; Dumotier B; De Clerck F
    J Cardiovasc Pharmacol; 2011 May; 57(5):589-97. PubMed ID: 21346598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of drug-induced QT interval prolongation in conscious rabbits.
    Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
    J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal variability of QT interval and changes in T wave morphology in dogs as markers of the clinical risk of drug-induced proarrhythmia.
    Hanton G; Yvon A; Racaud A
    J Pharmacol Toxicol Methods; 2008; 57(3):194-201. PubMed ID: 18472280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculation of QT shift in non clinical safety pharmacology studies.
    Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
    J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods of QT correction and periodic and continuous ECG recordings.
    Noel GJ; Goodman DB; Chien S; Solanki B; Padmanabhan M; Natarajan J
    J Clin Pharmacol; 2004 May; 44(5):464-73. PubMed ID: 15102866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
    Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
    J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
    Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
    J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.
    Testai L; Breschi MC; Martinotti E; Calderone V
    J Appl Toxicol; 2007; 27(3):270-5. PubMed ID: 17265420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
    Markert M; Shen R; Trautmann T; Guth B
    J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferences of the autonomic nervous system with drug induced QT prolongation: a point to consider in non-clinical safety studies.
    Champeroux P; Ouillé A; Martel E; Fowler JS; Maurin A; Jude S; Lala P; Le Guennec JY; Richard S
    J Pharmacol Toxicol Methods; 2010; 61(3):251-63. PubMed ID: 20172034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs.
    Dhillon SS; Dóró E; Magyary I; Egginton S; Sík A; Müller F
    PLoS One; 2013; 8(4):e60552. PubMed ID: 23579446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
    Kågström J; Sjögren EL; Ericson AC
    J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.